Összes szerző
Balog Erika
az alábbi absztraktok szerzői között szerepel:
-
Czigléczki Janka Zsófia
Functionally important C-terminus of small GTPase Ran: exploring its nucleotide-specific conformational surface -
Aug 30 - szerda
15:30 – 17:00
II. Poszterszekció
P39
Functionally important C-terminus of small GTPase Ran: exploring its nucleotide-specific conformational surface
Janka Czigleczki1, Pedro Tulio de Resende Lara2, Balint Dudas1,3,4, Hyunbum Jang5, David Perahia4, Ruth Nussinov 5,6and Erika Balog1
1Department of Biophysics and Radiation Biology, Semmelweis University, Budapest, Hungary
2Department of Medical Genetics and Genomic Medicine, School of Medical Sciences, University of Campinas—UNICAMP, Campinas, Brazil
3Inserm U1268 MCTR, CiTCoM UMR 8038 CNRS—Université Paris Cité, Paris, France
4Laboratoire et Biologie et Pharmacologie Appliquée, Ecole Normale Supérieure Paris-Saclay, Gif-sur-Yvette, France
5Computational Structural Biology Section, Frederick National Laboratory for Cancer Research in the Cancer Innovation Laboratory, National Cancer Institute, Frederick, MD, United States
6Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
As a member of the Ras superfamily of small GTPases, Ran (Ras-related Nuclear protein) is the main regulator of the nucleo-cytoplasmic transport through the nuclear core complex. It functions as a molecular switch cycling between the GDP-bound inactive or “off” and GTP-bound active or “on” state. Since deregulation of Ran is linked to numerous cancers from the stage of cancer initiation to metastasis, understanding the complexity of its interaction, especially the regulatory mechanism, is critical for drug discovery.
Ran consists of a globular (G) domain and a C-terminal region, which is bound to the G-domain in the inactive, GDP-bound states. The crystal structures of the GTP-bound active form complexed with Ran binding proteins (RanBP) show that the C-terminus undergoes a large conformational change, embracing Ran binding domains (RanBD), whereas in the crystal structures of macromolecular complexes not containing RanBDs the structure of the C-terminal segment remains unresolved, indicating its large conformational flexibility. This movement could not have been followed either by experimental or simulation methods. Here, by using molecular dynamics (MD) and MDeNM (Molecular Dynamics with excited Normal Modes) simulation methods, we present how rigid the C-terminal region is in the inactive RanGDP form and for the first time in the literature, we were able to follow its conformational flexibility in the GTP-bound form. This conformational mapping allows us to envisage how the C-terminus can embrace RanBDs during the function of Ran.
The simulations were carried out by JC, and were analyzed and interpreted by JC, PR, BD, HJ, RN, DP, and EB.
-
Liliom Károly
Conformational dynamics of human Calmodulin under low calcium loads. -
Aug 29 - kedd
15:30 – 17:00
I. Poszterszekció
P16
Conformational Dynamics of Human Calmodulin at Low Ca2+ Saturations
Gusztáv Schay1, Klaudia Onica2, Arian Jafari1, Franci Merzel3, Miklós Kellermayer1, Erika Balog1, and Károly Liliom1
1Department of Biophysics and Radiation Biology, Semmelweis University, Budapest, Hungary
2Pázmány Péter Catholic University, Budapest, Hungary
3National Institute of Chemistry, Ljubljana, Slovenia
Calmodulin is an extremely conservative key protein of intracellular signal transduction. It can bind four Ca2+-ions by two EF-hand motifs in its N- and C-terminal domains. During Ca2+-binding hidden hydrophobic surfaces become available, which take part in recognition of a broad range of target proteins. These observations led to the idea of calmodulin being a molecular switch, activating its partners when Ca2+-saturated at elevated intracellular calcium levels. It is known that calmodulin can adopt numerous conformational states, however, the change of conformers along Ca2+-binding is not known. Importantly, considering the intracellular calmodulin and Ca2+-levels, and the Ca2+-affinities of calmodulin EF-hands, it is unlikely that calmodulin gets Ca2+-saturated in physiologic signaling conditions. What is then the mechanism of target protein selection? The Ca2+-binding of calmodulin displays cooperativity which can be described by a Perutz binding model to explain Ca2+-saturation experiments in vitro. The function/conformation of calmodulin at low Ca2+-loads has not been explored yet in details, whereas all physiologic Ca2+-signaling happens at low Ca2+/calmodulin concentration ratio. Compartmentalization of target proteins and canonic binding modes of Ca2+-saturated calmodulin cannot account for why the spatiotemporal information content of intracellular Ca2+-signaling is not lost during calmodulin signal transduction.
Our experiments uncovered an increased conformational diversity at low Ca2+/calmodulin concentration ratio, and that the binding of model peptide melittin to calmodulin happened much before the Ca2+-saturation of the protein. We carried out molecular dynamics simulations of calmodulin with adding two Ca2+-ions to the C-terminal EF-hands of apocalmodulin and also by removing two Ca2+-ions from the N-terminal EF-hands of holocalmodulin. We observed striking differences in the structural dynamics of the N-terminal apo–C-terminal holo calmodulin, depending on the initial state from which we have reached this state. Based on our experiments and molecular dynamics calculations we hypothesize that the spatiotemporal changes in intracellular Ca2+-concentrations can be coded into the structural/conformational dynamics of calmodulin.
This work was supported by the grants FK-135517, TKP2021-EGA-23, and STIA-KFI-0012.
-
Tóth Dániel
Substrate selectivity of Sulfotransferase Isoenzymes, results based on Molecular Dynamics and Ensemble Docking -
Aug 30 - szerda
15:30 – 17:00
II. Poszterszekció
P58
Substrate selectivity of Sulfotransferase Isoenzymes, results based on Molecular Dynamics and Ensemble Docking
Dániel Toth1,2 , Bálint Dudas2,3, David Perahia3, Erika Balog1, Maria A. Miteva2
1Department of Biophysics and Radiation Biology, Semmelweis University, Hungary
2Inserm U1268 MCTR, CiTCoM UMR 8038 CNRS - Université Paris Cité, France
3Laboratoire de biologie et pharmacologie appliquee, Ecole Normale Superieure Paris-Saclay, France
Sulfotransferase enzymes (SULTs) are a family of cytosolic globular proteins in the chain of metabolism. By catalysing a sulfate transfer from their co-factor, 3′-Phosphoadenosine 5′-Phosphosulfate (PAPS), they eliminate a large variety of small molecules like drugs, hormones and neurotransmitters. Even though the tertiary structure across the family is very similar, their substrates vary considerably in size and complexity. The aim of our project is to better understand the reasons of selectivity between the different SULT isoenzymes, by comparing the broad targeting hepatic detoxifier SULT1A1, and the ileum located, dopamine selective SULT1A3.
Based on our previous results and Molecular Dynamics (MD) and Molecular Dynamics with excited Normal Modes (MDeNM), an extended conformational space of the PAPS-bound SULT1A1 was explored. Further developments of our method utilising ensemble docking with categorised ligands, a method known as Virtual Screening was achieved. Moreover, we have broadened our scope to use the same approach for the SULT1A3.
Based on our new results, we identified the key differences, that are responsible for changing the protein dynamics and binding mechanisms, by opening the binding pocket to an unfavourable conformation for the most common ligands of 1A1, thus acting as efficient selectors. These results can be helpful in the future to develop an algorithm for machine learning, that could differentiate and even predict new substrates of the different isoforms, thus helping in the development of ADME-Tox profiling of novel drug candidates and xenobiotics.
Acknowledgment
TKP2021 EGA 23, Ministry for Innovation and Technology in Hungary,
2021-0143339, Ministére francais de l’Europe et des Affaires Etrangéres
Tét-Balaton project „drug-drug interactions of sulfotransferases” ( 2019-2.1.11-TÉT-2020-00096 )